This company has been working on synthetic bone tissue and cartilage tissue scaffolds in the biomedical sector since 2017 as a technocity company. It continues its production and R&D activities with its 30 personnel with 520,000 cc capacity in 150-7 (Class 10000) at Ege University Technology Development Center and ISO-5 (Class 100), ISO-6 (Class 1000) and ISO-7 (Class 10000) clean room conditions in Manisa.

It is a biotech based company that focuses on the design, development, manufacture and marketing of innovative synthetic bone graft products. In addition to its high-tech production and quality control devices, it continues its R&D investment uninterruptedly, with the support of its expert employees and strong capital structure.

It is the largest of the three manufacturers in synthetic bone graft market of Turkey and is also biggest of the exporters. With its export-oriented growth strategy, it has completed its certification processes in 55 countries in 3 years and exports to these countries. The market it is addressing abroad is 3096 of the total market.

With the FDA approval, it will continue its growth studies in America and Asia-Pacific.

Spine surgery still works heavily and aims to grow rapidly in orthopedics and dental fields. As of 2021, it will increase its effectiveness in the market with 3 new products.